Identification of Pathogenic Copy Number Variants in Mexican Patients With Inherited Retinal Dystrophies Applying an Exome Sequencing Data‐Based Read‐Depth Approach
Molecular Genetics & Genomic Medicine · 2024
DOI: 10.1002/mgg3.70019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Gerardo E Fabian-Morales und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Institute of Ophthalmology "Conde de Valenciana", Mexico City, Mexico. Hauptthemen laut MEDLINE: DNA Copy Number Variations, Exome Sequencing, Retinal Dystrophies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Velux Stiftung.
Abstract (Originalsprache)
Background
Retinal dystrophies (RDs) are the most common cause of inherited blindness worldwide and are caused by genetic defects in about 300 different genes. While targeted next‐generation sequencing (NGS) has been demonstrated to be a reliable and efficient method to identify RD disease‐causing variants, it doesn't routinely identify pathogenic structural variant as copy number variations (CNVs). Targeted NGS‐based CNV detection has become a crucial step for RDs molecular diagnosis, particularly in cases without identified causative single nucleotide or Indels variants. Herein, we report the exome sequencing (ES) data‐based read‐depth bioinformatic analysis in a group of 30 unrelated Mexican RD patients with a negative or inconclusive genetic result after ES.
Methods
CNV detection was performed using ExomeDepth software, an R package designed to detect CNVs using exome data. Bioinformatic validation of identified CNVs was conducted through a commercially available CNV caller. All identified candidate pathogenic CNVs were orthogonally verified through quantitative PCR assays.
Results
Pathogenic or likely pathogenic CNVs were identified in 6 out of 30 cases (20%), and of them, a definitive molecular diagnosis was reached in 5 cases, for a final diagnostic rate of ~17%. CNV‐carrying genes included CLN3 (2 cases), ABCA4 (novel deletion), EYS , and RPGRIP1 .
Conclusions
Our results indicate that bioinformatic analysis of ES data is a reliable method for pathogenic CNV detection and that it should be incorporated in cases with a negative or inconclusive molecular result after ES.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Genetics, Institute of Ophthalmology "Conde de Valenciana", Mexico City, Mexico.
- Rare Diseases Diagnostic Unit, Faculty of Medicine, UNAM, Mexico City, Mexico.
- Faculty of Medicine, Autonomous University of the State of Morelos (UAEM), Morelos, Mexico.
- Faculty of Medicine, Department of Biochemistry, National Autonomous University of Mexico (UNAM), Mexico City, Mexico.
ORCID-Profile: Gerardo E Fabian-Morales, Juan C Zenteno
Förderung
- Velux Stiftung
Zitieren
APA
Fabian-Morales, G. E., Ordoñez-Labastida, V., Garcia-Martínez, F., Montes-Almanza, L., & Zenteno, J. C. (2024). Identification of Pathogenic Copy Number Variants in Mexican Patients With Inherited Retinal Dystrophies Applying an Exome Sequencing Data‐Based Read‐Depth Approach. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70019
Vancouver
Fabian-Morales GE, Ordoñez-Labastida V, Garcia-Martínez F, Montes-Almanza L, Zenteno JC. Identification of Pathogenic Copy Number Variants in Mexican Patients With Inherited Retinal Dystrophies Applying an Exome Sequencing Data‐Based Read‐Depth Approach. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.70019
BibTeX
@article{FabianMorales2024,
author = {Fabian-Morales, Gerardo E and Ordoñez-Labastida, Vianey and Garcia-Martínez, Froylan and Montes-Almanza, Luis and Zenteno, Juan C},
title = {Identification of Pathogenic Copy Number Variants in Mexican Patients With Inherited Retinal Dystrophies Applying an Exome Sequencing Data‐Based Read‐Depth Approach},
journal = {Molecular Genetics & Genomic Medicine},
year = {2024},
doi = {10.1002/mgg3.70019}
}
EUVIMED